Analysts See $0.22 EPS for Pfenex Inc. (PFNX); Pura Vida Investments Decreased Nanostring Technologies (NSTG) Stake By $1.99 Billion

March 14, 2018 - By Adrian Erickson

Analysts expect Pfenex Inc. (NYSEAMERICAN:PFNX) to report $0.22 EPS on March, 15 after the close.They anticipate $0.67 EPS change or 148.89% from last quarter’s $-0.45 EPS. PFNX’s profit would be $5.18M giving it 5.14 P/E if the $0.22 EPS is correct. After having $-0.37 EPS previously, Pfenex Inc.’s analysts see -159.46% EPS growth. The stock increased 3.91% or $0.17 during the last trading session, reaching $4.52. About 189,473 shares traded. Pfenex Inc. (NYSEAMERICAN:PFNX) has declined 30.30% since March 14, 2017 and is downtrending. It has underperformed by 47.00% the S&P500.

Pura Vida Investments Llc decreased Nanostring Technologies Inc (NSTG) stake by 30.94% reported in 2017Q3 SEC filing. Pura Vida Investments Llc sold 123,206 shares as Nanostring Technologies Inc (NSTG)’s stock declined 7.69%. The Pura Vida Investments Llc holds 275,000 shares with $4.44 billion value, down from 398,206 last quarter. Nanostring Technologies Inc now has $178.34 million valuation. The stock increased 3.39% or $0.23 during the last trading session, reaching $7.01. About 1.19M shares traded or 454.95% up from the average. NanoString Technologies, Inc. (NASDAQ:NSTG) has risen 32.04% since March 14, 2017 and is uptrending. It has outperformed by 15.34% the S&P500.

Among 4 analysts covering NanoString Technologies (NASDAQ:NSTG), 1 have Buy rating, 0 Sell and 3 Hold. Therefore 25% are positive. NanoString Technologies had 14 analyst reports since August 5, 2015 according to SRatingsIntel. The rating was initiated by Cowen & Co on Wednesday, September 30 with “Outperform”. Morgan Stanley maintained NanoString Technologies, Inc. (NASDAQ:NSTG) rating on Thursday, March 8. Morgan Stanley has “Equal-Weight” rating and $12 target. The rating was initiated by Janney Capital with “Buy” on Wednesday, March 16. The stock of NanoString Technologies, Inc. (NASDAQ:NSTG) earned “Neutral” rating by Janney Capital on Thursday, October 12. Cowen & Co maintained the stock with “Buy” rating in Wednesday, September 27 report. Cowen & Co maintained it with “Buy” rating and $2000 target in Monday, August 14 report. As per Wednesday, December 20, the company rating was maintained by Cowen & Co. The company was maintained on Wednesday, August 5 by Leerink Swann. The stock of NanoString Technologies, Inc. (NASDAQ:NSTG) has “Buy” rating given on Monday, October 23 by Robert W. Baird. The stock of NanoString Technologies, Inc. (NASDAQ:NSTG) earned “Outperform” rating by Robert W. Baird on Thursday, October 12.

Analysts await NanoString Technologies, Inc. (NASDAQ:NSTG) to report earnings on May, 3. They expect $-0.77 EPS, up 11.49% or $0.10 from last year’s $-0.87 per share. After $-0.34 actual EPS reported by NanoString Technologies, Inc. for the previous quarter, Wall Street now forecasts 126.47% negative EPS growth.

Investors sentiment decreased to 0.93 in 2017 Q3. Its down 0.97, from 1.9 in 2017Q2. It worsened, as 12 investors sold NSTG shares while 17 reduced holdings. 18 funds opened positions while 37 raised stakes. 21.83 million shares or 0.18% more from 21.79 million shares in 2017Q2 were reported. Pennsylvania-based Vanguard Gp has invested 0% in NanoString Technologies, Inc. (NASDAQ:NSTG). Los Angeles Cap Mgmt And Equity Inc holds 0% or 14,870 shares. State Street Corp owns 274,162 shares for 0% of their portfolio. 33,367 are owned by California State Teachers Retirement System. Goldman Sachs has invested 0% in NanoString Technologies, Inc. (NASDAQ:NSTG). Pura Vida Invs holds 2.23% of its portfolio in NanoString Technologies, Inc. (NASDAQ:NSTG) for 275,000 shares. 11,562 are held by Aqr Capital Mngmt Ltd Liability Company. Neuberger Berman Gru Limited Liability Company stated it has 0.01% in NanoString Technologies, Inc. (NASDAQ:NSTG). 1,257 are owned by Sei Investments. Pdts Prns Limited Liability Co invested in 57,000 shares or 0.03% of the stock. 13,052 were reported by Highbridge Cap Mngmt. The California-based Schwab Charles Investment Management Inc has invested 0% in NanoString Technologies, Inc. (NASDAQ:NSTG). Moreover, Tiaa Cref Invest Management Limited Liability has 0% invested in NanoString Technologies, Inc. (NASDAQ:NSTG). Tower Research Cap Llc (Trc) accumulated 2,167 shares or 0% of the stock. Gp One Trading Lp, a Illinois-based fund reported 587 shares.

Pura Vida Investments Llc increased Axogen Inc (NASDAQ:AXGN) stake by 49,909 shares to 229,278 valued at $4.44 billion in 2017Q3. It also upped Adamas Pharmaceuticals Inc (Call) (NASDAQ:ADMS) stake by 120,897 shares and now owns 200,000 shares. Agile Therapeutics Inc (NASDAQ:AGRX) was raised too.

Pfenex Inc., a clinical-stage biotechnology company, develops biosimilar therapeutics in the United States. The company has market cap of $106.44 million. The Company’s lead product candidates include PF708, a therapeutic equivalent candidate to Forteo for the treatment of osteoporosis; PF582, a biosimilar to Lucentis (ranibizumab) for the treatment of patients with retinal diseases; and Px563L, a novel anthrax vaccine candidate in Phase 1a trial. It currently has negative earnings. The firm also engages in developing a pipeline of additional biosimilar candidates, including PF529, a biosimilar candidate to Neulasta; PF688, a biosimilar candidate to Cimzia; PF530, a biosimilar candidate to Betaseron; PF690, a biosimilar candidate to the reference product Oncaspar; PF444-human growth hormone, a biosimilar candidate to Genotropin; and PF688-certolizumab-pegol, a biosimilar candidate to Cimzia.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Market News